drugset / Trial / NCT02564939

Ramelteon Prevention of Delirium - RCT

NCT02564939

Phase 4 Unknown 240 enrolled Hartford Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Delirium is a common morbid condition in hospitalized adults. Treatment of delirium has been unsatisfactory and prevention is the preferred goal. Based on limited experimental research, ramelteon appears to have promise for prevention. This study will evaluate ramelteon in prevention of delirium in a hospitalized adult population age 65+ in a double-blinded RCT.

Timeline

Start
2017-02-23
Primary completion
2018-12
Completion
2019-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ramelteon Unknown

Indications